| Product Code: ETC9945353 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Glaucoma Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Glaucoma Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Glaucoma Market - Industry Life Cycle |
3.4 United Kingdom (UK) Glaucoma Market - Porter's Five Forces |
3.5 United Kingdom (UK) Glaucoma Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United Kingdom (UK) Glaucoma Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 United Kingdom (UK) Glaucoma Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 United Kingdom (UK) Glaucoma Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 United Kingdom (UK) Glaucoma Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Kingdom (UK) Glaucoma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Aging population in the UK leading to a higher prevalence of glaucoma |
4.2.2 Technological advancements in glaucoma diagnostics and treatment options |
4.2.3 Increasing awareness and screening programs for early detection of glaucoma |
4.3 Market Restraints |
4.3.1 Limited access to specialized eye care services in certain regions of the UK |
4.3.2 High costs associated with glaucoma treatment and management |
4.3.3 Stringent regulatory requirements for approval of new glaucoma drugs and devices |
5 United Kingdom (UK) Glaucoma Market Trends |
6 United Kingdom (UK) Glaucoma Market, By Types |
6.1 United Kingdom (UK) Glaucoma Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Glaucoma Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Glaucoma Market Revenues & Volume, By Closed Angle Glaucoma (CAG), 2021- 2031F |
6.1.4 United Kingdom (UK) Glaucoma Market Revenues & Volume, By Open Angle Glaucoma (OAG), 2021- 2031F |
6.1.5 United Kingdom (UK) Glaucoma Market Revenues & Volume, By Secondary Glaucoma, 2021- 2031F |
6.1.6 United Kingdom (UK) Glaucoma Market Revenues & Volume, By Congenital Glaucoma, 2021- 2031F |
6.1.7 United Kingdom (UK) Glaucoma Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) Glaucoma Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Glaucoma Market Revenues & Volume, By Beta Blockers, 2021- 2031F |
6.2.3 United Kingdom (UK) Glaucoma Market Revenues & Volume, By Prostaglandins, 2021- 2031F |
6.2.4 United Kingdom (UK) Glaucoma Market Revenues & Volume, By Alpha Adrenergic Agonist, 2021- 2031F |
6.2.5 United Kingdom (UK) Glaucoma Market Revenues & Volume, By Carbonic Anhydrase Inhibitors, 2021- 2031F |
6.2.6 United Kingdom (UK) Glaucoma Market Revenues & Volume, By Combination Drugs, 2021- 2031F |
6.2.7 United Kingdom (UK) Glaucoma Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Kingdom (UK) Glaucoma Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Glaucoma Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 United Kingdom (UK) Glaucoma Market Revenues & Volume, By Injections, 2021- 2031F |
6.3.4 United Kingdom (UK) Glaucoma Market Revenues & Volume, By Intravitreal, 2021- 2031F |
6.3.5 United Kingdom (UK) Glaucoma Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Kingdom (UK) Glaucoma Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Glaucoma Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United Kingdom (UK) Glaucoma Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.4.4 United Kingdom (UK) Glaucoma Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United Kingdom (UK) Glaucoma Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Glaucoma Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 United Kingdom (UK) Glaucoma Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 United Kingdom (UK) Glaucoma Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 United Kingdom (UK) Glaucoma Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Glaucoma Market Export to Major Countries |
7.2 United Kingdom (UK) Glaucoma Market Imports from Major Countries |
8 United Kingdom (UK) Glaucoma Market Key Performance Indicators |
8.1 Rate of glaucoma screening in the UK population |
8.2 Adoption rate of new glaucoma treatment technologies |
8.3 Number of collaborations between healthcare providers and pharmaceutical companies in the glaucoma sector |
9 United Kingdom (UK) Glaucoma Market - Opportunity Assessment |
9.1 United Kingdom (UK) Glaucoma Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United Kingdom (UK) Glaucoma Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 United Kingdom (UK) Glaucoma Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 United Kingdom (UK) Glaucoma Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 United Kingdom (UK) Glaucoma Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Kingdom (UK) Glaucoma Market - Competitive Landscape |
10.1 United Kingdom (UK) Glaucoma Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Glaucoma Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here